High-throughput virtual screening and preclinical analysis identifies CB-1, a novel potent dual B-Raf/c-Raf inhibitor, effective against wild and mutant variants of B-Raf expression in colorectal carcinoma.
Mesfer Al ShahraniMohammad AbohassanMohammad Y. AlshahraniAbdulrahim R. HakamiPrasanna RajagopalanPublished in: J. Comput. Aided Mol. Des. (2021)